McKesson Corporation Fights a Clawback Policy Proposed by Big Investors
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Should one of the largest drug wholesalers have a clawback policy for executives? Two institutional investors believe the notion is overdue for McKesson, since the wholesaler has paid more than $1 billion in recent years to resolve regulatory and other legal disputes without publicly disclosing any clawback steps. Meanwhile, McKesson ceo John Hammergren received $131 million in compensation last year. And so, the LongView Funds run by Amalgamated Bank and the UAW Retiree Medical Benefits Trust are pushing a proposal to be voted on at the McKesson annual shareholder meeting tomorrow.
Help employers find you! Check out all the jobs and post your resume.
Should one of the largest drug wholesalers have a clawback policy for executives? Two institutional investors believe the notion is overdue for McKesson, since the wholesaler has paid more than $1 billion in recent years to resolve regulatory and other legal disputes without publicly disclosing any clawback steps. Meanwhile, McKesson ceo John Hammergren received $131 million in compensation last year. And so, the LongView Funds run by Amalgamated Bank and the UAW Retiree Medical Benefits Trust are pushing a proposal to be voted on at the McKesson annual shareholder meeting tomorrow.
Help employers find you! Check out all the jobs and post your resume.